fluorodeoxyglucose f18 has been researched along with Atherogenesis in 202 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 43 (21.29) | 29.6817 |
| 2010's | 120 (59.41) | 24.3611 |
| 2020's | 39 (19.31) | 2.80 |
| Authors | Studies |
|---|---|
| Ayappa, I; Fayad, Z; Kundel, V; Mani, V; Redline, S; Reid, M; Rueschman, M; Shah, N; Shea, S | 1 |
| Chen, M; Kapoor, P; Keel, A; Manyak, G; Mehta, NN; Osborne, MT; Pantoja, C; Parel, P; Patel, NH; Playford, MP; Rodante, JA; Scott, C; Sorokin, AV; Svirydava, M; Tawakol, A; Teague, H; Teklu, M; Zhou, W | 1 |
| Prigent, K; Vigne, J | 1 |
| Abdelwahed, YS; Bigalke, B; Botnar, RM; Brenner, W; Engel, LC; Fröhlich, G; Furth, C; Haghikia, A; Hamm, B; Landmesser, U; Leistner, DM; Makowski, MR; Morguet, A; Noutsias, M; Schulze, D; Schuster, A; Skurk, C; Wurster, TH | 1 |
| Roivainen, A; Saraste, A; Ståhle, M | 1 |
| Alavi, A; Høilund-Carlsen, PF; Revheim, ME; Werner, TJ | 1 |
| Bentsen, S; Binderup, T; Grandjean, CE; Jensen, JK; Kjaer, A; Ripa, RS | 1 |
| Andrés, V; Bueno, H; Devesa, A; España, S; Fernández-Friera, L; Fernández-Ortiz, A; Fuster, JJ; Fuster, V; García-Lunar, I; Ibanez, B; Lobo-González, M; Martínez-Milla, J; Mastrangelo, A; Mendiguren, JM; Oliva, B; Rossello, X; Sanchez-Gonzalez, J; Sancho, D; Sanz, J | 1 |
| Brits, B; Davis, C; Hlongwa, KN; Lawal, IO; Mahapane, J; Maserumule, LC; Mokoala, KMG; Ndlovu, H; Popoola, GO; Sathekge, MM | 1 |
| Jensen, JK; Jensen, MEK; Kjaer, A; Madsen, JS; Ripa, RS | 1 |
| Alavi, A; Gerke, O; Høilund-Carlsen, PF; Madsen, PL; Piri, R; Revheim, ME; Sturek, M; Werner, TJ | 1 |
| Abdelhafez, Y; Badawi, RD; Bengel, FM; Cherry, SR; Derlin, T; Mamach, M; Nardo, L; Spencer, BA | 1 |
| Alavi, A; Lau, HC; Naseer, R; Ng, SJ; Raynor, WY; Sandhu, S; Werner, TJ | 1 |
| Al-Enezi, MS; Bentourkia, M; Berrahmoune, N; Croteau, É; Douhi, A; Fulop, T; Khalil, A; Nguyen, M; Turcotte, E | 1 |
| Ehrlichmann, W; Feil, R; Feil, S; Kneilling, M; Pichler, BJ; Reischl, G; Schörg, BF; Stowbur, D | 1 |
| Aarntzen, EHJG; Janssen, AWM; Riksen, NP; Stienstra, R; Tack, CJ; van Diepen, JA; van Heck, JIP | 1 |
| Akarriou, M; Bacour, YAA; Comans, EFI; de Vet, HCW; Smit, F; Smulders, YM; van der Laken, CJ; van Kanten, MP; Voskuyl, AE | 1 |
| Abohashem, S; Arechiga, VM; Chow, FC; Epel, ES; Hsue, PY; Iaccarino, L; La Joie, R; Mundada, NS; Rabinovici, GD; Swaminathan, S; Tawakol, A | 1 |
| Blennow, K; Cortes-Canteli, M; Fernandez-Ortiz, A; Fuster, V; Garcia-Alvarez, A; Garcia-Lunar, I; Gispert, JD; Ibanez, B; Moreno-Arciniegas, A; Moro, MA; Oliva, B; Perez-Herreras, C; Sanchez-Gonzalez, J; Schöll, M; Suárez-Calvet, M; Tristão-Pereira, C; Zetterberg, H | 1 |
| Bueno, H; de Vega, VM; Devesa, A; España, S; Fernández-Friera, L; Fernández-Ortiz, A; Fuster, V; García-Alvarez, A; García-Lunar, I; Ibanez, B; Lara-Pezzi, E; Moreno-Arciniegas, A; Oliva, B; Perez-Herreras, C; Rossello, X; Sanchez-Gonzalez, J; Sanz, J; Trivieri, MG; Vazirani, R | 1 |
| Liu, L; Ma, J; Wang, J; Wang, M; Zhang, C; Zhang, J | 1 |
| Ahmadi, A; Beanlands, R; Boczar, KE; Chong, AY; deKemp, RA; Dowlatshahi, D; Garrard, L; Kelly, C; Lefebvre, C; Leung, E; Liu, P; Lochnan, H; MacPhee, P; MacPherson, PA; Raggi, P; Shin, S; Tavoosi, A; Tawakol, A; Tilokee, E; Torres, C; Wells, GA; Wiefels, C | 1 |
| Al-Mashhadi, RH; Al-Mashhadi, Z; Bentzon, JF; Bjørklund, MM; Bloch, LØ; Falk, E; Frøkiær, J; Nasr, ZP; Tolbod, LP; Winterdahl, M | 1 |
| Chowdhury, MM; Evans, NR; Le, EPV; Rudd, JHF; Sriranjan, RS; Tarkin, JM | 1 |
| Liu, C; Pucar, D | 1 |
| Boellaard, R; Borra, RJH; de Boer, SA; Greuter, MJ; Hillebrands, JL; Lambers Heerspink, HJ; Lefrandt, JD; Mulder, DJ; Reijrink, M; Slart, RHJA; Spoor, DS | 1 |
| Jiang, Y; Li, L; Li, M; Wu, W; Zhang, P | 1 |
| Al-Hijji, M; Benscoter, M; Burke, M; Franchi, F; Krier, J; Lerman, A; Noble, C; Olthoff, M; Ramaswamy, V; Rodriguez-Porcel, M; Sandhu, GS; Witt, T | 1 |
| Collins, CD; Dodd, JD; Killeen, RP; Liddy, S; Mallia, A; Murphy, DJ; Skehan, S; Subesinghe, M | 1 |
| Gomez, MF; Hellberg, S; Huusko, J; Knuuti, J; Liljenbäck, H; Nuutila, P; Roivainen, A; Saraste, A; Silvola, JMU; Söderström, M; Ståhle, M; Virta, J; Ylä-Herttuala, S | 1 |
| Al-Mallah, MH; Hyafil, F; Santulli, G | 1 |
| Ćorović, A; Mason, JC; Rudd, JHF; Tarkin, JM; Wall, C | 1 |
| Benz, DC; Buechel, RR; Dorbala, S | 1 |
| Advani, RH; Doan, BH; Iagaru, A; Jarr, KU; Kojima, Y; Leeper, NJ; Nakamoto, R; Weissman, IL | 1 |
| Cortes-Canteli, M; Falcon, C; Fernandez-Friera, L; Fernandez-Ortiz, A; Fuster, V; Garcia-Ruiz, JM; Gispert, JD; Ibanez, B; Mendiguren, J; Molinuevo, JL; Oliva, B; Salvadó, G; Sanchez-Gonzalez, J; Sanz, J; Toribio-Fernandez, R; Tristão-Pereira, C | 1 |
| Gottesman, RF; Parikh, NS | 1 |
| Hoogeveen, RM; Kaiser, Y; Kroon, J; Moens, SJB; Stroes, ESG; Verberne, HJ; Verweij, SL; Vogt, L | 1 |
| Kitagawa, T; Nakano, Y | 1 |
| Fayad, ZA; Giannarelli, C; Jacobi, A; Mani, V; Naidu, S; Sahota, A; Woodward, M | 1 |
| Alexander, MY; Bruce, IN; Cristinacce, PLH; Hatsukami, T; Hockings, PD; James, J; Pemberton, P; Skeoch, S; Sun, J; Waterton, JC; Williams, H; Xu, D; Yuan, C | 1 |
| Asada, Y; Iwakiri, T; Kawai, K; Kitamura, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Sugita, C; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y | 1 |
| Hellberg, S; Jauhiainen, M; Knuuti, J; Liljenbäck, H; Metso, J; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Savisto, N; Silvola, JMU; Sippola, S; Ståhle, M; Virta, J; Ylä-Herttuala, S | 1 |
| Bauwens, M; Boswijk, E; Bucerius, J; Mottaghy, FM; Wildberger, JE | 1 |
| Chul Paeng, J; Joung, C; Jung, SM; Kim, C; Kim, S; Kim, WK; Lee, YS; Pahk, K; Woo Byun, J; Yong Park, J; Young Song, H | 1 |
| Asmis, R; Downs, K; Goins, B; Jerabek, PA; Lai, Y; Nguyen, HN; Sadeghi, MM; Short, JD; Tavakoli, S; Toczek, J | 1 |
| Jun, S; Nam, HY | 1 |
| Feng, T; Li, J; Nie, M; Xu, J; Xu, Z; Yan, Y; Zhang, M; Zhao, Q; Zhao, X | 1 |
| Cook, R; Dey, AK; Eder, L; Gladman, DD; Joshi, AA; Mehta, NN; Siegel, EL | 1 |
| Ahlman, MA; Bluemke, DA; Dave, J; Herscovitch, P; Maass-Moreno, R; Mallek, MB; Mehta, NN; Sadek, A; Sandfort, V; Selwaness, MAF; Vigneault, DM | 1 |
| Bekkering, S; Bernelot Moens, SJ; Duivenvoorden, R; Nahrendorf, M; Nurmohamed, NS; Stiekema, LCA; Stroes, ESG; van der Valk, FM; Verberne, HJ; Versloot, M; Verweij, SL | 1 |
| El Mahdiui, M; Kikuchi, T; Manabe, O; Nishii, R; Scholte, AJHA; Suzuki, E; Yoshinaga, K; Zhang, MR | 1 |
| Celeng, C; de Jong, P; de Keizer, B; Leiner, T; Merkely, B; Takx, RAP | 1 |
| Hyafil, F; Mikail, N; Sinigaglia, M | 1 |
| Andrews, JPM; Dweck, MR; Fayad, ZA | 1 |
| Hyafil, F; Vigne, J | 1 |
| Alessio, A; Berman, DS; Cadet, S; Dey, D; Doris, MK; Dweck, MR; Krishnan, SK; Kwiecinski, J; Newby, DE; Otaki, Y; Pan, T; Rubeaux, M; Slomka, PJ | 1 |
| Alavi, A; Alloosh, M; Houshmand, S; Høilund-Carlsen, PF; McKenney-Drake, ML; Moe, S; Moghbel, MC; Paydary, K; Salavati, A; Sturek, JM; Sturek, M; Territo, PR; Weaver, C; Werner, TJ | 1 |
| Bae, JH; Cho, YS; Choi, JY; Hyun, SH; Kim, BT; Lee, KH; Moon, SH | 1 |
| Choi, KM; Lee, YB | 1 |
| Al-Zaghal, A; Alavi, A; Constantinescu, CM; Høilund-Carlsen, PF; Moghbel, M; Werner, TJ | 1 |
| Cardo, AG; Chaparro, MÁS; Espíldora, J; Hidalgo, CM; Lillo, E; Palomo, L; Trigo, JM; Valdivielso, P; Villena García, AC | 1 |
| Arai-Okuda, H; Ihara, A; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Tanaka, K; Yamamoto, Y | 1 |
| Bhatt, DL; Blankstein, R; Libby, P | 1 |
| Christoffersen, BØ; Forman, JL; Hansen, AE; Johannesen, HH; Kirk, RK; Kjaer, A; Klausen, TL; Löfgren, J; Ludvigsen, TP; Olsen, LH; Pedersen, HD; Pedersen, SF; Ripa, RS; Schumacher-Petersen, C; Vegge, A; Ørbæk, M | 1 |
| Fujimoto, K; Hino, A; Inoue, T; Ishibashi, M; Kaida, H; Kurata, S; Shizukuishi, K; Tateishi, U; Yoneyama, T | 1 |
| Bodholdt, RP; Hag, AM; Kjaer, A; Pedersen, SF; Ripa, RS | 1 |
| Brady, TJ; Corsini, E; Fontanez, S; Hoffmann, U; Kaplan, R; Lawler, M; Singh, P; Subramanian, S; Tawakol, A; Vijayakumar, J | 1 |
| Ballet, S; Bini, J; Corot, C; Dickson, SD; Fayad, ZA; Izquierdo-Garcia, D; Klink, A; Lancelot, E; Mateo de Castro, J; Millon, A; Robert, P | 1 |
| Ishino, S; Kubo, K; Magata, Y; Mori, I; Nishimoto, T; Ogawa, M; Satomi, T | 1 |
| Abdelbaky, A; Alon, A; Beals, CR; Dansky, H; Farkouh, ME; Fayad, ZA; Klimas, MT; Mogg, R; Nunes, IO; Rudd, JH; Shankar, SS; Subramanian, SS; Tawakol, A | 1 |
| Asada, Y; Iwakiri, T; Kawai, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Ohe, K; Okuyama, N; Sugita, C; Tamaki, N; Yamashita, A; Zhao, S; Zhao, Y | 1 |
| Asmis, R; Tavakoli, S; Ullevig, S; Zamora, D | 1 |
| Daemen, MJ; Marsch, E; Sluimer, JC | 1 |
| Bamberg, F; Hacker, M; Nikolaou, K; Reiser, MF; Rist, C; Rominger, A; Saam, T; Strobl, FF; Thierfelder, KM; Uebleis, C; Wolpers, S | 1 |
| Kaikita, K; Ogawa, H | 1 |
| Feng, TT; Li, DP; Li, LQ; Liu, Y; Zhang, MD; Zhao, QM; Zhao, X; Zhao, XC; Zhuang, XC | 1 |
| Alonso-Farto, JC; de Vega, VM; Fayad, ZA; Fernández-Friera, L; Fernández-Ortiz, A; Fuster, V; García, L; Guallar, E; Ibañez, B; Jiménez-Borreguero, LJ; Laclaustra, M; López-Melgar, B; Mendiguren, JM; Mocoroa, A; Molina, J; Ordovás, JM; Peñalvo, JL; Rudd, JH; Sanz, G; Sillesen, H | 1 |
| Gersak, B; Jezovnik, MK; Lezaic, L; Poredos, P; Zidar, N | 1 |
| Asada, Y; Iwakiri, T; Kawai, K; Koshimoto, C; Kuge, Y; Matsuura, Y; Moriguchi-Goto, S; Okuyama, N; Sugita, C; Tamaki, N; Yamasaki, K; Yamashita, A; Zhao, S; Zhao, Y | 1 |
| Feng, TT; Su, G; Zhang, MD; Zhang, XX; Zhao, QM; Zhao, X; Zhao, XC; Zhuang, XC | 1 |
| Angiletta, D; Ciccone, MM; Cortese, F; Di Palo, A; Gesualdo, M; Marzullo, A; Niccoli Asabella, A; Regina, G; Rubini, G; Scicchitano, P; Zito, A | 1 |
| Higaki, J; Miyagawa, M; Mochizuki, T; Nishiyama, Y; Ogimoto, A; Yokoyama, R | 1 |
| Joshi, FR; Rudd, JH; Tarkin, JM | 1 |
| Sadeghi, MM | 1 |
| Broisat, A; Desruet, MD; Fagret, D; Ghezzi, C; Perret, P; Riou, LM; Toczek, J | 1 |
| Bathon, JM; Corsini, E; Emami, H; Hoffmann, U; MacNabb, MH; Singh, P; Solomon, DH; Subramanian, S; Tawakol, A; Vijayakumar, J; Vucic, E | 1 |
| Emami, H; Fayad, ZA; Figueroa, A; Hemphill, LC; Hovingh, GK; Kastelein, JJ; Koopman, MG; Lobatto, ME; MacNabb, MH; Mulder, WJ; Schulte, DM; Sjouke, B; Stroes, ES; Tawakol, A; van der Valk, FM; van Wijk, DF; Verberne, HJ | 1 |
| Abiru, N; Ando, T; Chiba, K; Haraguchi, A; Hayashida, N; Kamasaki, T; Kawakami, A; Kudo, T; Miyamoto, I; Takamura, N; Usui, T; Yamasaki, H | 1 |
| Blomberg, BA; Høilund-Carlsen, PF | 1 |
| Abdelbaky, A; Ballantyne, CM; Baruch, A; Duprez, DA; Fayad, ZA; Fredrickson, J; Frendeus, B; Ghoshhajra, B; Hsieh, F; Koren, M; Korsgren, M; Lehrer-Graiwer, J; Rosenson, RS; Roth, EM; Rudd, JHF; Singh, P; Tang, MT; Tawakol, AA; van Bruggen, N; Vucic, E | 1 |
| Baik, SH; Choi, DS; Choi, HY; Choi, KM; Hong, HC; Hwang, SY; Kim, NH; Kim, S; Kim, SG; Seo, JA; Yoo, HJ | 1 |
| Joshi, FR; Rajani, NK; Rudd, JH; Tarkin, JM | 1 |
| Brouwer, E; Comans, EF; Glaudemans, AW; Lensen, KD; Pereira Arias-Bouda, LM; Slart, RH; Smulders, YM; van der Laken, CJ; Voskuyl, AE; Zwijnenburg, AT | 1 |
| Alavi, A; deGoma, EM; Dunbar, RL; Litt, HI; Mehta, NN; Mohler, ER; Pollan, L; Rader, DJ; Saboury, B; Salavati, A; Schoen, M; Shinohara, RT; Torigian, DA; Woo, J | 1 |
| Chen, W; Dilsizian, V | 1 |
| Burg, S; Buvat, I; Huet, P; Hyafil, F; Le Guludec, D | 1 |
| Chevalier-Mathias, E; Karcher, G; Kauffmann, C; Lamiral, Z; Mandry, D; Marie, PY; Mathias, J; Meneroux, B; Micard, E; Morel, O; Rossignol, P; Verger, A | 1 |
| Fukao, K; Hamada, T; Kubo, N; Kuge, Y; Nakano, T; Shimizu, Y; Tamaki, N; Ukon, N; Watanabe, A; Yamasaki, K; Zhao, S; Zhao, Y | 1 |
| Alavi, A; Gholami, S; Houshmand, S; Salavati, A; Werner, TJ | 1 |
| Bartenstein, P; Habs, M; Hacker, M; Hetterich, H; Reiser, MF; Rominger, A; Saam, T; Volpers, S; Walter, L | 1 |
| Abdelbaky, A; Ballantyne, CM; Du, S; Ehlgen, A; Emami, H; Farkouh, ME; Farmer, M; Fayad, ZA; Hayes, W; Kim, J; Langenickel, TH; Li, L; Mohler, ER; Roth, E; Subramanian, S; Tawakol, A; Velasquez, L; Vucic, E | 1 |
| Buscombe, JR | 1 |
| Heinonen, I; Knuuti, J; Metsälä, O; Pietilä, M; Rinne, P; Roivainen, A; Saraste, A; Saukko, P; Saunavaara, V; Savisto, N; Savunen, T; Stark, C; Strandberg, M; Tarkia, M; Teräs, M; Teuho, J; Tolvanen, T; Vähäsilta, T | 1 |
| Alam, SR; Carruthers, K; Dweck, MR; Fletcher, AM; Fox, KA; Hoo, TY; Jenkins, WS; Joshi, NV; Langlands, SP; Melville, AJ; Mills, NL; Newby, DE; Rudd, JH; Shah, AS; Sills, A; Toor, I; Uren, NG; van Beek, EJ; Vesey, AT | 1 |
| Belanger, AP; Binderup, T; Calcagno, C; Courties, G; Di Carli, MF; Dubey, S; Fayad, ZA; Ishino, S; Iwamoto, Y; Johnbeck, CB; Keliher, EJ; Kjaer, A; Knigge, U; Libby, P; Mani, V; Mulder, WJ; Nahrendorf, M; Pérez-Medina, C; Swirski, FK; Tang, J; Tawakol, A; Weissleder, R; Wojtkiewicz, GR; Ye, YX | 1 |
| Bilbao, I; España, S; Mateo, J; Ruiz-Cabello, J; Vaquero, JJ | 1 |
| Alavi, A; Grupe, P; Houshmand, S; Høilund-Carlsen, PF; Salavati, A; Segtnan, EA | 1 |
| Bala, G; Blykers, A; Broisat, A; Caveliers, V; Cosyns, B; Descamps, B; Devoogdt, N; Droogmans, S; Fagret, D; Ghezzi, C; Hernot, S; Lahoutte, T; Van Camp, G; Vanhove, C; Xavier, C | 1 |
| Balatsos, N; Castejón, B; Cuadrado, I; Herruzo, I; Martin, AM; Saura, M; Zamorano, JL; Zaragoza, C | 1 |
| Alavi, A; Bural, GG; Rubello, D; Torigian, D | 1 |
| Berent, R; Brammen, L; Sinzinger, H; Steiner, S | 1 |
| Joseph, P; Tawakol, A | 1 |
| Al-Mashhadi, AL; Al-Mashhadi, RH; Baruch, A; Bentzon, JF; Drouet, L; Falk, E; Fredrickson, J; Frendéus, B; Frøkiær, J; Larsen, JR; Moestrup, SK; Nielsen, LB; Poulsen, CB; Robertson, AK; Tawakol, A; Thygesen, J; Tolbod, L; von Wachenfeldt, K; Vucic, E | 1 |
| Bucerius, J | 1 |
| Faust, A; Hermann, S; Honold, L; Schäfers, M; Vrachimis, A | 1 |
| Bugden, M; Duan, Y; Gaudet, C; Kamkar, M; Marcel, YL; Mitchel, RE; Petryk, J; Priest, ND; Ruddy, TD; Wei, L; Wells, RG; Wyatt, HM | 1 |
| Pipitone, N; Salvarani, C; Versari, A | 1 |
| Tamaki, N | 1 |
| Ali, A; Calcagno, C; Fayad, ZA; Figueroa, AL; Hoffmann, U; Ishai, A; Kaiser, Y; Mani, V; Mulder, WJ; Murrough, JW; Nahrendorf, M; Pitman, RK; Shin, LM; Solomon, CJ; Takx, RA; Tang, CY; Tawakol, A; Truong, QA | 1 |
| de Boer, SA; Glaudemans, AW; Heerspink, HJ; Hovinga-de Boer, MC; Juárez Orozco, LE; Kamphuisen, PW; Lefrandt, JD; Mulder, DJ; Slart, RH; van Roon, AM | 1 |
| Baerlecken, NT; Bengel, FM; Daehnrich, C; Derlin, T; Ernst, D; Schlumberger, W; Schmidt, RE; Weiberg, D; Witte, T | 1 |
| Jacobsson, H; Larsson, S; Sundin, A; Wassélius, J | 1 |
| Ishino, S; Kamihashi, J; Kita, T; Kuge, Y; Kume, N; Minami, M; Mukai, T; Ogawa, M; Saji, H; Shiomi, M; Takai, N | 1 |
| Blankenberg, FG; Kuge, Y; Strauss, HW; Tamaki, N; Zhao, S; Zhao, Y | 1 |
| Badimon, JJ; Buchsbaum, MS; Fayad, ZA; Fuster, V; Helft, G; Liew, GY; Machac, J; Tang, C; Worthley, MI; Worthley, SG; Zaman, AG; Zhang, ZY | 1 |
| Alavi, A; Bural, GG; Chen, W; Rader, DJ; Torigian, DA | 1 |
| van der Laarse, A; van der Wall, EE | 1 |
| Bax, JJ; Jukema, JW; Schuijf, JD; van der Laarse, A; van der Wall, EE | 1 |
| Arnolda, LF; Beer, C; Eikelboom, JW; Hankey, GJ; Lenzo, N; Potter, K | 1 |
| Jacobsson, H; Larsson, S; Wassélius, J | 1 |
| Imaizumi, T; Narula, J; Tahara, N; Virmani, R | 1 |
| Cornily, JC; Fayad, ZA; Feldman, LJ; Hyafil, F; Machac, J; Rudd, JH | 1 |
| Cullum, I; Dickson, JC; Ell, PJ; Endozo, R; Groves, AM; Hutton, BF; Kotze, CW; Menezes, LJ; Yusuf, SW | 1 |
| Aidi, HE; Farkouh, M; Fayad, ZA; Fuster, V; Mani, V; Rudd, JH; Silvera, SS; Yang, L | 1 |
| Elkhawad, M; Fayad, ZA; Rudd, JH | 1 |
| Bartenstein, P; Cyran, CC; Foerster, S; Hacker, M; Nikolaou, K; Reiser, MF; Rominger, A; Saam, T; Schmidt, M; Wolpers, S | 1 |
| Aigbirhio, FI; Bird, JL; Davenport, AP; Davies, JR; Figg, N; Fryer, TD; Izquierdo-Garcia, D; Richards, HK; Rudd, JH; Warburton, EA; Weissberg, PL | 1 |
| Bansilal, S; Farkouh, ME; Fayad, ZA; Fuster, V; Machac, J; Myers, KS; Rudd, JH; Woodward, M | 1 |
| Shah, PK | 1 |
| Aikawa, E; Figueiredo, JL; Hembrador, S; Keliher, E; Kelly, K; Libby, P; Nahrendorf, M; Panizzi, P; Weissleder, R; Zhang, H | 1 |
| Bird, JL; Clark, JC; Davenport, AP; Davies, JR; Figg, N; Izquierdo-Garcia, D; Probst, KC; Rudd, JH; Warburton, EA; Weissberg, PL | 1 |
| Kai, H | 1 |
| Fisker Hag, AM; Graebe, M; Højgaard, L; Kjaer, A; Pedersen, SF; Sillesen, H | 1 |
| Ben-Haim, S; Ell, PJ; Groves, AM; Hutton, B; Kayani, I; Menezes, LJ | 1 |
| Bartenstein, P; Hacker, M; Nikolaou, K; Reiser, MF; Rist, C; Rominger, A; Saam, T | 1 |
| Bartenstein, P; Becker, A; Cumming, P; Foerster, S; Greif, M; Hacker, M; Nikolaou, K; Reiser, MF; Rist, C; Rominger, A; Saam, T; Wolpers, S | 1 |
| Benedetto, R; Carneiro, MP; Coutinho, A; Fonseca, LM; Junqueira, FA; von Ristow, A | 1 |
| Fayad, ZA; Glover, DK; Johnson, LL; Lanza, GM; Sadeghi, MM | 1 |
| Manukova, VA; Panchkovskaia, EV; Rudas, MS; Sergienko, VB | 1 |
| Fayad, ZA; Fuster, V; Klimas, M; Machac, J; Narula, J; Rudd, JH; Strauss, HW; Tahara, N; Tawakol, AA; Virmani, R; Warburton, EA | 1 |
| Baik, SH; Choi, DS; Choi, HY; Choi, KM; Kim, NH; Kim, S; Kim, SG; Park, MS; Seo, JA; Yang, SJ; Yoo, HJ | 1 |
| Choudhury, RP; Fayad, ZA; Lindsay, AC; Owen, DR | 1 |
| Amano, T; Aoyama, T; Hayashi, M; Ishii, H; Matsubara, T; Murohara, T; Nishio, M; Takahashi, H; Tamaki, T; Tanaka, M; Toriyama, T; Yoshikawa, D | 1 |
| Bordes, S; Joshi, F; Rosenbaum, D; Rudd, JH | 1 |
| Feng, TT; Li, DP; Li, LQ; Liu, Y; Su, G; Xu, ZM; Zhang, XX; Zhao, QM; Zhao, X | 1 |
| Ruddy, TD; Small, GR | 1 |
| Apostolova, I; Buchert, R; Derlin, T; Habermann, CR; Hahne, JD; Klutmann, S; Mester, J | 1 |
| Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kodama, N; Mizoguchi, M; Mohar, D; Nitta, Y; Tahara, A; Tahara, N; Yamagishi, S | 1 |
| Christen, T; Di Carli, MF; Folco, EJ; Libby, P; Rocha, VZ; Sheikine, Y; Shvartz, E; Sukhova, GK | 1 |
| Nguyen, PK; Wu, JC | 1 |
| Calcagno, C; Dickson, SD; Fayad, ZA; Fisher, EA; Fuster, V; Hayashi, K; Lin, J; Moon, MJ; Moshier, E; Mounessa, JS; Nicolay, K; Roytman, M; Rudd, JH; Tsimikas, S; Vucic, E | 1 |
| Finn, AV; Tawakol, A | 1 |
| Brady, TJ; Cury, RC; Figueroa, AL; Gardecki, JA; Hoffmann, U; Subramanian, SS; Tawakol, A; Tearney, GJ; Truong, QA | 1 |
| Chen, MF; Chi, YC; Huang, CL; Huang, PJ; Kao, HL; Lin, HJ; Lin, LY; Lin, YH; Tzen, KY; Wang, YC; Wu, YW; Yang, WS; Yen, RF | 1 |
| Heinonen, SE; Knuuti, J; Laine, VJ; Laitinen, I; Nuutila, P; Roivainen, A; Saraste, A; Saukko, P; Savisto, N; Silvola, JM; Ylä-Herttuala, S | 1 |
| Buettner, C; Fayad, ZA; Rudd, JH | 1 |
| Hoit, BD; Longenecker, CT | 1 |
| Hermann, S; Kuhlmann, M; Schäfers, M; Schober, O; Starsichova, A; Waschkau, B; Wenning, C | 1 |
| Camici, PG; Gaemperli, O; Libby, P; Rimoldi, OE | 1 |
| Fayad, ZA; Millon, A; Rosenbaum, D | 1 |
| Hayabuchi, N; Honda, A; Imaizumi, T; Ishibashi, M; Kaida, H; Kodama, N; Matsui, T; Mizoguchi, M; Nitta, Y; Tahara, A; Tahara, N; Takeuchi, M; Yamagishi, S | 1 |
| Cai, G; Cheriyan, J; Choudhury, RP; Collier, DJ; Davies, LC; Davis, B; Elkhawad, M; Fayad, ZA; Gleeson, FV; Lepore, JJ; Marber, MS; Rudd, JH; Sarov-Blat, L; Sprecher, DL; Tawakol, A; Wells, R; Wilkinson, IB; Willette, RN | 1 |
| Beanlands, RS; Cocker, MS; Dekemp, RA; Hammond, RR; Lum, C; Mc Ardle, B; McDonald, MA; Ongaro, DC; Spence, JD; Tardif, JC | 1 |
| Bissonnette, R; Bolduc, C; Guertin, MC; Harel, F; Pressacco, J; Tardif, JC | 1 |
| Binderup, T; Christoffersen, C; Hag, AM; Jensen, MM; Jørgensen, JT; Kjaer, A; Pedersen, SF; Ripa, RS; Skovgaard, D | 1 |
| Alavi, A; Kwee, TC; Torigian, DA | 1 |
| Nakadate, M; Ryu, Y; Shibuya, H; Suzuki, Y; Tomita, M; Umehara, I; Yoshida, K | 1 |
| Baird, A; Boon, NA; Dweck, MR; Joshi, NV; Khaw, HJ; Luo, EL; Makiello, P; Mirsadraee, S; Newby, DE; Rudd, JH; Sng, GK; van Beek, EJ; Williams, MC | 1 |
| Ametamey, SM; Buck, A; Kaufmann, PA; Lacal, JC; Lohmann, C; Lüscher, TF; Matter, CM; Meier, P; Ramirez de Molina, A; Späth, N; von Lukowicz, T; von Schulthess, GK; Weber, B; Wyss, MT | 1 |
| Ibaraki, M; Kitamura, K; Miura, S; Okane, K; Satoh, T; Satomi, J; Shimosegawa, E; Sugawara, S; Takahashi, K; Toyoshima, H | 1 |
| Davies, JR; Narula, J; Rudd, JH; Weissberg, PL | 1 |
| Ghazarossian, V; Mari, C; Patt, BE; Strauss, HW | 1 |
| Hosokawa, R; Kambara, N; Kita, T; Kume, N; Motomura, H; Mukai, T; Nohara, R; Ogawa, M; Ohba, M; Saji, H | 1 |
| Haaparanta, M; Knuuti, J; Laine, VJ; Laitinen, I; Leppänen, P; Marjamäki, P; Roivainen, A; Savisto, N; Soini, SL; Wilson, I; Ylä-Herttuala, S | 1 |
| Fayad, ZA; Frias, JC; Lipinski, MJ | 1 |
| Hatano, K; Ishino, S; Ito, K; Kato, T; Magata, Y; Mukai, T; Ogawa, M; Saji, H; Shiomi, M | 1 |
| Bashian, GG; Bedri, S; Brady, TJ; Cury, RC; Fischman, AJ; Furie, K; Gewirtz, H; Houser, S; LaMuraglia, GM; Migrino, RQ; Muller, JE; Tawakol, A; Vermylen, D; Yates, D | 1 |
| Baba, K; Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kai, H; Kaida, H; Nakaura, H; Tahara, N | 1 |
| Alavi, A; Alkhawaldeh, K; Bural, GG; Chamroonrat, W; El-Haddad, G; Houseni, M; Torigian, DA | 1 |
| Zaret, BL | 1 |
| Blankenberg, FG; Inubushi, M; Kuge, Y; Morita, K; Strauss, HW; Tamaki, N; Zhao, S; Zhao, Y | 1 |
| Fayad, ZA; Machac, J; Rudd, JH | 1 |
| Alavi, A; Basu, S; Zhuang, H | 1 |
| Baba, K; Hayabuchi, N; Imaizumi, T; Ishibashi, M; Kai, H; Kaida, H; Mizoguchi, M; Nakaura, H; Tahara, N | 1 |
| Bansilal, S; Farkouh, M; Fayad, ZA; Fuster, V; Machac, J; Myers, KS; Rafique, A; Rudd, JH | 1 |
| Alavi, A; Basu, S; Bural, GG; Chamroonrat, W; Chen, W; Houseni, M; Kumar, R; Torigian, DA | 1 |
| Dunphy, MP; Schoder, H; Strauss, HW | 1 |
| Fayad, ZA; Myers, KS; Rudd, JH; Sanz, J | 1 |
| Baron, JC; Izquierdo, D; Moustafa, RR; Warburton, EA; Weissberg, PL | 1 |
| Abela, GS; Aziz, K; Berger, K; Claycombe, K; Huang, R; Patel, R | 1 |
| Briley-Saebo, KC; Calcagno, C; Cornily, JC; Fayad, ZA; Fuster, V; Goldschlager, G; Hyafil, F; Machac, J; Mani, V; Rudd, JH | 1 |
| Bansilal, S; Farkouh, M; Fayad, ZA; Fuster, V; Hargeaves, R; Machac, J; Myers, KS; Pinto, CA; Rafique, A; Rudd, JH; Tong, C | 1 |
46 review(s) available for fluorodeoxyglucose f18 and Atherogenesis
| Article | Year |
|---|---|
Advances in Radiopharmaceutical Sciences for Vascular Inflammation Imaging: Focus on Clinical Applications.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Radiopharmaceuticals | 2021 |
Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging.
Topics: Atherosclerosis; Diabetes Mellitus; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Atherosclerosis Imaging: Positron Emission Tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2023 |
Imaging findings and clinical relevance of
Topics: Atherosclerosis; Calcinosis; Clinical Relevance; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Receptors, CXCR4 | 2023 |
Atherosclerosis imaging using PET: Insights and applications.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Vascular findings on FDG PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Aortic Diseases; Aortitis; Atherosclerosis; Blood Vessel Prosthesis; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Prosthesis-Related Infections; Radiopharmaceuticals; Vascular Diseases; Vasculitis | 2020 |
Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography | 2017 |
PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis.
Topics: Atherosclerosis; Coronary Vessels; Fluorescent Dyes; Fluorodeoxyglucose F18; Humans; Indocyanine Green; Injections, Intravenous; Plaque, Atherosclerotic; Positron-Emission Tomography; Spectroscopy, Near-Infrared; Tomography, Optical Coherence | 2018 |
New methods to image unstable atherosclerotic plaques.
Topics: Annexin A5; Apoptosis; Atherosclerosis; Coronary Artery Disease; Diagnostic Imaging; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Hypoxia; Inflammation; Ligands; Magnetic Resonance Imaging; Myocardial Infarction; Neovascularization, Physiologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2018 |
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Sodium Fluoride | 2018 |
Diet-Modulated Lipoprotein Metabolism and Vascular Inflammation Evaluated by
Topics: Animals; Apolipoproteins B; Atherosclerosis; Diet; Fluorodeoxyglucose F18; Humans; Inflammation; Lipoproteins; Lipoproteins, LDL; Macrophages; Positron-Emission Tomography; Vasculitis | 2018 |
The Role of PET in Evaluating Atherosclerosis: A Critical Review.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sodium Fluoride | 2018 |
Small animal positron emission tomography imaging and in vivo studies of atherosclerosis.
Topics: Animals; Atherosclerosis; Biomarkers; Body Size; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Molecular Imaging; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Translational Research, Biomedical | 2013 |
Hypoxia in atherosclerosis and inflammation.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Lipid Metabolism; Macrophages; Magnetic Resonance Angiography; Plaque, Atherosclerotic; Radiography; Signal Transduction | 2013 |
Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.
Topics: Animals; Arteritis; Atherosclerosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Insurance, Health; Japan; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sarcoidosis | 2014 |
PET imaging of inflammation in atherosclerosis.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
(18)F-FDG PET and vascular inflammation: time to refine the paradigm?
Topics: Algorithms; Atherosclerosis; Computer Simulation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Models, Cardiovascular; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Vasculitis | 2015 |
[¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Image Enhancement; Patient Positioning; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
PET imaging of atherosclerosis.
Topics: Atherosclerosis; Calcinosis; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia; Inflammation; Neovascularization, Pathologic; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Stroke; Tomography, X-Ray Computed | 2015 |
Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Topics: Algorithms; Atherosclerosis; Carotid Arteries; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Likelihood Functions; Magnetic Resonance Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.
Topics: Algorithms; Atherosclerosis; Blood Glucose; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).
Topics: Aortic Aneurysm; Atherosclerosis; Coronary Vessels; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Vascular Calcification; Vasculitis | 2015 |
Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings.
Topics: Atherosclerosis; Breast Neoplasms; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Metal Nanoparticles; Mice; Mice, Knockout; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiography; Radiopharmaceuticals; Receptors, LDL | 2016 |
Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
Topics: Animals; Arteries; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index; Sodium Fluoride | 2016 |
Imaging atherosclerosis with positron emission tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Monitoring Vasculitis with 18F-FDG PET.
Topics: Adult; Aged; Algorithms; Animals; Atherosclerosis; Computed Tomography Angiography; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Angiography; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Systemic Vasculitis; Takayasu Arteritis; Vasculitis; Whole Body Imaging | 2016 |
New molecular probes of vascular inflammation.
Topics: Animals; Apoptosis; Atherosclerosis; Calcinosis; Cardiology; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Mice; Molecular Probes; Neovascularization, Pathologic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Translational Research, Biomedical | 2016 |
Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries.
Topics: Angiography; Animals; Arteries; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis.
Topics: Annexin A5; Atherosclerosis; Carotid Stenosis; Coronary Angiography; Fluorodeoxyglucose F18; Humans; Inflammation; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Technetium | 2009 |
Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Imaging atherosclerosis and vulnerable plaque.
Topics: Animals; Atherosclerosis; Clinical Trials as Topic; Contrast Media; Extracellular Matrix; Ferric Compounds; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Nanoparticles; Neovascularization, Pathologic; Risk; Thrombosis; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?
Topics: Animals; Arteries; Atherosclerosis; Biopsy, Needle; Cohort Studies; Coronary Artery Disease; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Male; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Severity of Illness Index | 2010 |
Imaging of atherosclerosis.
Topics: Animals; Atherosclerosis; Carotid Artery Diseases; Carotid Stenosis; Constriction, Pathologic; Endothelium, Vascular; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mice; Plaque, Atherosclerotic; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Vascular imaging with positron emission tomography.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Glucose; Humans; Inflammation; Macrophages; Positron-Emission Tomography; Radiopharmaceuticals | 2011 |
PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality?
Topics: Aortic Diseases; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2011 |
Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond.
Topics: Atherosclerosis; Brachial Artery; Carotid Intima-Media Thickness; Coronary Vessels; Endothelium, Vascular; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Magnetic Resonance Angiography; Molecular Imaging; Plaque, Atherosclerotic; Radiography; Tomography, Emission-Computed; Tomography, Optical Coherence | 2012 |
Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Matrix Metalloproteinases; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque.
Topics: Animals; Atherosclerosis; Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Hemorrhage; Humans; Isoquinolines; Mice; Microbubbles; Monocytes; Plaque, Atherosclerotic; Rabbits; Radiopharmaceuticals; Receptors, GABA; Tunica Intima; Vascular Calcification | 2012 |
Molecular imaging in atherosclerosis: FDG PET.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Molecular Imaging; Positron-Emission Tomography | 2012 |
Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Nononcological applications of positron emission tomography for evaluation of the thorax.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Idiopathic Interstitial Pneumonias; Infections; Positron-Emission Tomography; Pulmonary Disease, Chronic Obstructive; Radiopharmaceuticals; Respiratory Distress Syndrome; Sarcoidosis; Thoracic Diseases; Thorax | 2013 |
Radionuclide imaging for the detection of inflammation in vulnerable plaques.
Topics: Animals; Apoptosis; Atherosclerosis; Fluorodeoxyglucose F18; Foam Cells; Humans; Inflammation; Macrophages; Matrix Metalloproteinases; Monocytes; Phagocytosis; Positron-Emission Tomography; Radiopharmaceuticals | 2006 |
Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage.
Topics: Animals; Atherosclerosis; Contrast Media; Fluorodeoxyglucose F18; Humans; Macrophages; Models, Biological; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Multimodality imaging of atherosclerosis (magnetic resonance imaging/computed tomography/positron emission tomography-computed tomography).
Topics: Animals; Atherosclerosis; Calcinosis; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2007 |
18 trial(s) available for fluorodeoxyglucose f18 and Atherogenesis
| Article | Year |
|---|---|
Bone marrow activation in response to metabolic syndrome and early atherosclerosis.
Topics: Atherosclerosis; Biomarkers; Bone Marrow; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Metabolic Syndrome; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
Topics: Anti-Inflammatory Agents; Arteritis; Atherosclerosis; Biomarkers; C-Reactive Protein; Canada; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Humans; Inflammation; Interleukin-6; Ischemic Attack, Transient; Multicenter Studies as Topic; Positron Emission Tomography Computed Tomography; Prediabetic State; Prospective Studies; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Stroke; Tomography, X-Ray Computed | 2023 |
Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Carotid Arteries; Double-Blind Method; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Pyrroles; Treatment Outcome | 2013 |
FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.
Topics: Antibodies, Monoclonal; Atherosclerosis; Biomarkers; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Lipoproteins, LDL; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recombinant Proteins | 2015 |
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
Topics: Aorta; Aspirin; Atherosclerosis; Carotid Arteries; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hypolipidemic Agents; Inflammation; Lipids; Magnetic Resonance Spectroscopy; Male; Multimodal Imaging; Niacin; Pilot Projects; Placebos; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
Topics: Aged; Anti-Inflammatory Agents; Aortic Diseases; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Middle Aged; Multimodal Imaging; p38 Mitogen-Activated Protein Kinases; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrroles; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazines; United States | 2015 |
Atherosclerotic 18F-FDG and MDP uptake in femoral arteries, changes with age.
Topics: Adult; Aged; Aged, 80 and over; Aging; Atherosclerosis; Disease Progression; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Radiopharmaceuticals; Technetium Tc 99m Medronate; Whole Body Imaging | 2016 |
Do we need FDG-PET/CT to assess atherosclerosis?
Topics: Adult; Aged; Aorta, Thoracic; Aortitis; Atherosclerosis; Causality; Comorbidity; Denmark; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sodium Fluoride; Survival Rate; Vascular Calcification; Young Adult | 2017 |
Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Aorta; Arteritis; Atherosclerosis; Brachial Artery; Carotid Arteries; Cross-Sectional Studies; Double-Blind Method; Drug Combinations; Female; Femoral Artery; Fluorodeoxyglucose F18; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stroke; Time Factors; Treatment Outcome; Ultrasonography; Vasodilation; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2009 |
Gene expression and 18FDG uptake in atherosclerotic carotid plaques.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Biological Transport; Biomarkers; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Glycolysis; Humans; Male; Middle Aged; Polymerase Chain Reaction | 2010 |
[Positron emission tomography in the diagnosis of atherosclerotic plaques in cancer patients].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sex Factors | 2010 |
Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Aorta; Atherosclerosis; Atorvastatin; Dose-Response Relationship, Drug; Dyslipidemias; Female; Femoral Artery; Fluorodeoxyglucose F18; Heptanoic Acids; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Pyrroles; Treatment Outcome | 2010 |
The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers.
Topics: Abdominal Fat; Adult; Aged; Anti-Inflammatory Agents; Arteritis; Atherosclerosis; Atorvastatin; Biomarkers; Calcium; Female; Fluorodeoxyglucose F18; Heptanoic Acids; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pyrroles; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vascular Calcification | 2012 |
Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
Topics: Aged; Anti-Inflammatory Agents; Aortitis; Atherosclerosis; Carotid Artery Diseases; Cyclopropanes; Double-Blind Method; Female; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Intra-Abdominal Fat; Male; Middle Aged; Multimodal Imaging; Odds Ratio; p38 Mitogen-Activated Protein Kinases; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Subcutaneous Fat; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; United Kingdom | 2012 |
Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Atherosclerosis; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Psoriasis; Radiopharmaceuticals; Single-Blind Method; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation?
Topics: Aged; Aortic Valve; Aortic Valve Stenosis; Atherosclerosis; Bone Density; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Male; Osteitis; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride; Tomography, X-Ray Computed; Vasculitis | 2013 |
18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Carotid Arteries; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thoracic Arteries; Tomography, X-Ray Computed | 2006 |
Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Topics: Aged; Aorta, Thoracic; Atherosclerosis; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Simvastatin | 2006 |
138 other study(ies) available for fluorodeoxyglucose f18 and Atherogenesis
| Article | Year |
|---|---|
Sleep duration and vascular inflammation using hybrid positron emission tomography/magnetic resonance imaging: results from the Multi-Ethnic Study of Atherosclerosis.
Topics: Aged; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Spectroscopy; Male; Middle Aged; Positron-Emission Tomography; Sleep | 2021 |
Heightened splenic and bone marrow uptake of
Topics: Atherosclerosis; Bone Marrow; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Psoriasis; Radiopharmaceuticals; Spleen | 2021 |
Simultaneous [18F]fluoride and gadobutrol enhanced coronary positron emission tomography/magnetic resonance imaging for in vivo plaque characterization.
Topics: Aged; Atherosclerosis; Coronary Artery Disease; Fluorides; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Organometallic Compounds; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2022 |
Positron Emission Tomography in Atherosclerosis Research.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals | 2022 |
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not.
Topics: Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sodium Fluoride | 2022 |
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis.
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Glucagon-Like Peptides; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
[
Topics: Atherosclerosis; Cardiovascular Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Disease Risk Factors; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Vena Cava, Superior | 2022 |
[
Topics: Atherosclerosis; Benchmarking; Carotid Arteries; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies | 2023 |
Exploring Vessel Wall Biology In Vivo by Ultrasensitive Total-Body PET.
Topics: Arteries; Atherosclerosis; Biology; Fluorodeoxyglucose F18; Humans; Risk Factors | 2023 |
Non-calcified active atherosclerosis plaque detection with 18F-NaF and 18F-FDG PET/CT dynamic imaging.
Topics: Aged; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Humans; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in Mice.
Topics: Animals; Atherosclerosis; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Positron-Emission Tomography | 2023 |
Arterial wall inflammation assessed by 18F-FDG-PET/CT is higher in individuals with Type 1 diabetes and associated with circulating inflammatory proteins.
Topics: Arteritis; Atherosclerosis; Biomarkers; Carotid Arteries; Diabetes Mellitus, Type 1; Fluorodeoxyglucose F18; Humans; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis.
Topics: Arteritis; Atherosclerosis; Cell Differentiation; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results | 2023 |
Psychological stress is associated with arterial inflammation in people living with treated HIV infection.
Topics: Arteritis; Atherosclerosis; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Inflammation; Male; Middle Aged; Stress, Psychological | 2023 |
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.
Topics: Atherosclerosis; Cardiovascular Diseases; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Glucose; Heart Disease Risk Factors; Humans; Longitudinal Studies; Male; Middle Aged; Neurodegenerative Diseases; Prospective Studies; Risk Factors | 2023 |
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.
Topics: Atherosclerosis; Female; Fluorodeoxyglucose F18; Heart; Humans; Insulin Resistance; Male; Metabolic Syndrome; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Topics: Animals; Arteries; Atherosclerosis; Female; Fluorodeoxyglucose F18; Male; Positron-Emission Tomography; Radiopharmaceuticals; Swine; Swine, Miniature; Tissue Distribution | 2019 |
Standardization and quantification is a key to the future of atherosclerosis FDG PET/CT imaging.
Topics: Aorta; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
Topics: Adiposity; Adult; Aged; Atherosclerosis; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Obesity, Abdominal; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, X-Ray Computed | 2019 |
Biomechanical characteristics of isolated carotid atherosclerotic plaques assessed by ultrasonography.
Topics: Aged; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Linear Models; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Pulse Wave Analysis; ROC Curve; Sensitivity and Specificity | 2019 |
A Metabolic Intravascular Platform to Study FDG Uptake in Vascular Injury.
Topics: Animals; Aorta; Aortitis; Atherosclerosis; Biosensing Techniques; Disease Models, Animal; Energy Metabolism; Fluorodeoxyglucose F18; Macrophages; Optical Fibers; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Signal Processing, Computer-Assisted; Vascular System Injuries | 2020 |
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Mice, Knockout; Plaque, Atherosclerotic; Positron-Emission Tomography | 2020 |
No pleotropic effects of linagliptin on atherosclerotic plaques: Case closed.
Topics: Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Inflammation; Linagliptin; Mice; Plaque, Atherosclerotic | 2020 |
(18)F-sodium fluoride PET in multiple myeloma: Linking cancer to atherosclerosis?
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Multiple Myeloma; Positron-Emission Tomography; Sodium Fluoride | 2021 |
Effect of CD47 Blockade on Vascular Inflammation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Atherosclerosis; Carotid Artery Diseases; CD47 Antigen; Female; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2021 |
Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study.
Topics: Adult; Asymptomatic Diseases; Atherosclerosis; Brain; Carotid Arteries; Cohort Studies; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Ultrasonography | 2021 |
Midlife Cardiovascular Risk Factors, Subclinical Atherosclerosis, and Cerebral Hypometabolism.
Topics: Atherosclerosis; Cardiovascular Diseases; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Positron-Emission Tomography; Risk Factors | 2021 |
Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease.
Topics: Aged; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Carotid Arteries; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Renal Insufficiency, Chronic; Risk Factors | 2021 |
Innovative atherosclerosis imaging using
Topics: Atherosclerosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Sodium Fluoride | 2022 |
Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR.
Topics: Adolescent; Atherosclerosis; Electronic Nicotine Delivery Systems; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography; Smokers; Young Adult | 2021 |
Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation.
Topics: Arthritis, Rheumatoid; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Vascular Calcification | 2017 |
Altered glucose metabolism and hypoxic response in alloxan-induced diabetic atherosclerosis in rabbits.
Topics: Alloxan; Animals; Apoptosis; Atherosclerosis; Autoradiography; Body Weight; Cluster Analysis; Diabetes Mellitus, Experimental; Diet, High-Fat; Electrophoresis, Capillary; Femoral Artery; Fluorodeoxyglucose F18; Glucose; Glycolysis; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Macrophages; Mass Spectrometry; Metabolomics; Microscopy, Fluorescence; Nitroimidazoles; Principal Component Analysis; Rabbits | 2017 |
Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [
Topics: Animal Feed; Animals; Aortic Diseases; Apolipoprotein B-100; Atherosclerosis; Atorvastatin; Diet, Fat-Restricted; Diet, High-Fat; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Mice, Knockout; Phenotype; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, LDL; Time Factors | 2017 |
Visualization of Synthetic Vascular Smooth Muscle Cells in Atherosclerotic Carotid Rat Arteries by F-18 FDG PET.
Topics: Actins; Animals; Atherosclerosis; Carotid Arteries; Disease Models, Animal; Extracellular Matrix Proteins; Fluorodeoxyglucose F18; Hyperplasia; Muscle, Smooth, Vascular; Neointima; Positron-Emission Tomography; Rats; Smooth Muscle Myosins | 2017 |
Characterization of Macrophage Polarization States Using Combined Measurement of 2-Deoxyglucose and Glutamine Accumulation: Implications for Imaging of Atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Autoradiography; Deoxyglucose; Fluorodeoxyglucose F18; Glutamine; Macrophages; Mice; Plaque, Atherosclerotic; Positron-Emission Tomography | 2017 |
Association between active brown adipose tissue and coronary artery calcification in healthy men.
Topics: Adipose Tissue, Brown; Adult; Atherosclerosis; Biomarkers; Calcinosis; Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
Effect of pioglitazone on inflammation and calcification in atherosclerotic rabbits : An
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Hypoglycemic Agents; Inflammation; Male; Pioglitazone; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Random Allocation; Tomography, X-Ray Computed | 2018 |
Association of Tumor Necrosis Factor Inhibitor Treatment With Reduced Indices of Subclinical Atherosclerosis in Patients With Psoriatic Disease.
Topics: Adult; Aged; Antirheumatic Agents; Atherosclerosis; Canada; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Prospective Studies; Psoriasis; Risk Factors; Tumor Necrosis Factor-alpha | 2018 |
Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials.
Topics: Aged; Atherosclerosis; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Vasculitis | 2017 |
CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease.
Topics: Aged; Arteries; Arteritis; Atherosclerosis; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monocytes; Phenotype; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, CCR2 | 2018 |
Radiopharmaceutical tracers for cardiac imaging.
Topics: Apoptosis; Atherosclerosis; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2018 |
Could FDG-PET imaging play a role in the detection of progressing atherosclerosis in HIV-infected patients?
Topics: Arteritis; Atherosclerosis; Cross-Sectional Studies; Fluorodeoxyglucose F18; HIV; HIV Infections; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2019 |
Imaging inflammation in atherosclerotic plaques: Just make it easy!
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Indium Radioisotopes; Inflammation; Lymphocyte Function-Associated Antigen-1; Plaque, Atherosclerotic; Positron-Emission Tomography | 2019 |
Optimization of reconstruction and quantification of motion-corrected coronary PET-CT.
Topics: Aged; Atherosclerosis; Diastole; Electrocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Motion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Signal-To-Noise Ratio | 2020 |
Serum uric acid in asymptomatic adults is weakly associated with carotid artery FDG uptake but not intima-media thickness.
Topics: Adult; Asymptomatic Diseases; Atherosclerosis; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Uric Acid | 2020 |
18FDG PET/CT & arterial inflammation: predicting cardiovascular events in lung cancer.
Topics: Aged; Aorta, Abdominal; Aorta, Thoracic; Arteritis; Atherosclerosis; Calcinosis; Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Proportional Hazards Models; Retrospective Studies; Risk Factors | 2019 |
Regional
Topics: Adult; Aorta; Atherosclerosis; Coronary Vessel Anomalies; Coronary Vessels; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Imaging, Three-Dimensional; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pulmonary Artery; Sarcoidosis; Tomography, X-Ray Computed | 2020 |
Arterial Inflammation: The Heat Before the Storm.
Topics: Arteritis; Atherosclerosis; Fluorodeoxyglucose F18; Hot Temperature; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography | 2019 |
Topics: Animals; Atherosclerosis; Correlation of Data; Disease Models, Animal; Fluorodeoxyglucose F18; Gene Expression; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Swine; Swine, Miniature | 2019 |
Assessment of atherosclerosis in oncologic patients using ¹⁸F-fluoride PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Organ Specificity; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed | 2013 |
Arterial inflammation in bronchial asthma.
Topics: Adult; Aged; Aorta; Arteritis; Asthma; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Respiratory Function Tests; Retrospective Studies; Tomography, X-Ray Computed | 2013 |
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Topics: Animals; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Atorvastatin; Contrast Media; Dextrans; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Magnetic Resonance Imaging; Magnetite Nanoparticles; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Rabbits; Radiography; Radiopharmaceuticals; Time Factors | 2013 |
Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide.
Topics: Atherosclerosis; Biological Transport; Cell Line; Cells, Cultured; Contrast Media; Ferric Compounds; Fluorodeoxyglucose F18; Gene Expression Regulation; Glucose; Humans; Macrophages; Magnets; Molecular Imaging; Particle Size | 2013 |
Arterial (18)F-fluorodeoxyglucose uptake reflects balloon catheter-induced thrombus formation and tissue factor expression via nuclear factor-κB in rabbit atherosclerotic lesions.
Topics: Animals; Atherosclerosis; Catheters; Fluorodeoxyglucose F18; Gene Expression Regulation; Magnetic Resonance Angiography; Male; NF-kappa B; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiography; Radiopharmaceuticals; Thromboplastin; Thrombosis | 2013 |
Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis.
Topics: Animals; Atherosclerosis; Cell Polarity; Cells, Cultured; Energy Metabolism; Fluorodeoxyglucose F18; Macrophages; Mice; Mice, Inbred C57BL; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study.
Topics: Adult; Age Factors; Aged; Aorta, Abdominal; Aorta, Thoracic; Atherosclerosis; Carotid Artery, Common; Comorbidity; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Germany; Humans; Hyperlipidemias; Hypertension; Iliac Artery; Linear Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Obesity; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors; Sex Factors; Smoking; Tomography, X-Ray Computed; Vascular Calcification; Vasculitis; Whole Body Imaging | 2013 |
[(18)F]-fluorodeoxyglucose. A new imaging modality for atherosclerotic plaque thrombogenicity.
Topics: Animals; Atherosclerosis; Catheters; Fluorodeoxyglucose F18; Magnetic Resonance Angiography; Male; NF-kappa B; Positron-Emission Tomography; Radiopharmaceuticals; Thromboplastin; Thrombosis | 2013 |
[Noninvasive imaging of vulnerable plaques and thromboses with PET/CT complex imaging technique].
Topics: Angiography; Animals; Atherosclerosis; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Thrombosis | 2013 |
The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: rationale and design.
Topics: Adult; Aorta, Abdominal; Arteries; Asymptomatic Diseases; Atherosclerosis; Carotid Arteries; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Spain; Tomography, X-Ray Computed; Ultrasonography; Vascular Calcification | 2013 |
Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Artery, Internal; Carotid Stenosis; Endarterectomy, Carotid; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, X-Ray Computed | 2014 |
Increased metabolite levels of glycolysis and pentose phosphate pathway in rabbit atherosclerotic arteries and hypoxic macrophage.
Topics: Active Transport, Cell Nucleus; Animals; Atherosclerosis; Cell Hypoxia; Cell Line; Femoral Artery; Fluorodeoxyglucose F18; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Macrophages; Male; Metabolome; Pentose Phosphate Pathway; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Thromboplastin; Tissue Distribution | 2014 |
Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT.
Topics: Animals; Aorta; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Inflammation; Male; Multimodal Imaging; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Thrombosis; Tomography, X-Ray Computed | 2014 |
Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Carotid Artery Diseases; Endarterectomy, Carotid; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Macrophages; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Periaortic brown adipose tissue as a major determinant of [¹⁸F]-fluorodeoxyglucose vascular uptake in atherosclerosis-prone, apoE-/- mice.
Topics: Adipose Tissue, Brown; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body Weight; Female; Fluorodeoxyglucose F18; Mice; Mice, Knockout; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2014 |
Arterial 18F-FDG uptake in rheumatoid arthritis correlates with synovial activity.
Topics: Aorta; Aortitis; Arthritis, Rheumatoid; Atherosclerosis; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Synovial Membrane | 2014 |
Nonpharmacological lipoprotein apheresis reduces arterial inflammation in familial hypercholesterolemia.
Topics: Aged; Arteries; Atherosclerosis; Blood Component Removal; Case-Control Studies; Cholesterol, LDL; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Hyperlipoproteinemia Type II; Inflammation; Lipoproteins; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Risk Factors; Tomography, X-Ray Computed | 2014 |
Uptake of aortic 18F-FDG is correlated with low-density lipoprotein cholesterol and leptin in a general population.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Atherosclerosis; Biomarkers; Cholesterol, LDL; Female; Fluorodeoxyglucose F18; Humans; Japan; Leptin; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed | 2014 |
Vascular inflammation in metabolically abnormal but normal-weight and metabolically healthy obese individuals analyzed with ¹⁸F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Atherosclerosis; Body Mass Index; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Obesity; Phenotype; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2015 |
Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.
Topics: Aged; Arteries; Atherosclerosis; Female; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Inflammation; Male; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Vasculitis | 2015 |
PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR?
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Inflammation; Positron-Emission Tomography | 2015 |
Evidence of Cyclic Changes in the Metabolism of Abdominal Aortic Aneurysms During Growth Phases: ¹⁸F-FDG PET Sequential Observational Study.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Aortic Aneurysm, Abdominal; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Autoradiography; Biphenyl Compounds; Body Weight; Disease Progression; Fluorodeoxyglucose F18; Hyperlipidemias; Inflammation; Irbesartan; Male; Mice, Knockout; Positron-Emission Tomography; Rabbits; Renin-Angiotensin System; Tetrazoles | 2015 |
Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
Topics: Aged; Aged, 80 and over; Aorta; Aortic Diseases; Aortography; Arteries; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Iliac Artery; Linear Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Vascular Calcification | 2016 |
[18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs.
Topics: Animals; Atherosclerosis; Autoradiography; Blood Glucose; Cholesterol; Coronary Circulation; Coronary Vessels; Diabetes Mellitus; Fasting; Fluorodeoxyglucose F18; Microvessels; Myocardium; Positron-Emission Tomography; Sus scrofa; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction.
Topics: Aged; Aortitis; Atherosclerosis; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Myocardial Infarction; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Registries; Risk Factors; Scotland; Time Factors; Tomography, X-Ray Computed; Troponin | 2015 |
Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Bone Marrow; Carotid Artery Diseases; Cell Proliferation; Cholesterol, Dietary; Dideoxynucleosides; Diet, High-Fat; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cells; Humans; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Retrospective Studies; Spleen; Time Factors; Tomography, X-Ray Computed | 2015 |
In Vivo ¹⁸F-FDG-PET Imaging in Mouse Atherosclerosis.
Topics: Animals; Atherosclerosis; Disease Models, Animal; Equipment Design; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Image Interpretation, Computer-Assisted; Mice, Transgenic; Molecular Imaging; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2015 |
Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.
Topics: Analysis of Variance; Animals; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Endothelial Cells; Female; Fluorodeoxyglucose F18; In Vitro Techniques; Inflammation; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Random Allocation; Sensitivity and Specificity; Single-Domain Antibodies; Vascular Cell Adhesion Molecule-1 | 2016 |
Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions.
Topics: Animals; Antibodies, Monoclonal; Atherosclerosis; Cathepsins; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Humans; Hypercholesterolemia; Lipids; Positron-Emission Tomography; Recombinant Proteins; Swine; Treatment Outcome | 2016 |
Evaluation of Apoptosis with 99mTc-rhAnnexin V-128 and Inflammation with 18F-FDG in a Low-Dose Irradiation Model of Atherosclerosis in Apolipoprotein E-Deficient Mice.
Topics: Animals; Annexin A5; Apolipoproteins E; Apoptosis; Atherosclerosis; Dose-Response Relationship, Radiation; Female; Fluorodeoxyglucose F18; Mice; Mice, Knockout; Organotechnetium Compounds; Radiopharmaceuticals; Vasculitis; Whole-Body Irradiation | 2016 |
2016 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine.
Topics: Atherosclerosis; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Nuclear Medicine; Positron-Emission Tomography; Societies, Medical; Tomography, Emission-Computed, Single-Photon | 2016 |
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.
Topics: Aged; Amygdala; Arteries; Atherosclerosis; Bone Marrow; Cardiovascular Diseases; Cross-Sectional Studies; Fluorodeoxyglucose F18; Hematopoiesis; Humans; Inflammation; Longitudinal Studies; Middle Aged; Perception; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Risk Factors; Stress, Psychological | 2017 |
Effect of Linagliptin on Arterial
Topics: Administration, Oral; Aged; Arteries; Atherosclerosis; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Fluorodeoxyglucose F18; Humans; Linagliptin; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Vascular Stiffness | 2017 |
Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on
Topics: Adult; Atherosclerosis; Autoantibodies; Biomarkers; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Protein Array Analysis; Radiopharmaceuticals; Serologic Tests; Severity of Illness Index; Transcription Factors | 2017 |
Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atherosclerosis; Cardiovascular Diseases; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2009 |
Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque.
Topics: Animals; Antibodies, Monoclonal; Aorta; Atherosclerosis; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Hyperlipidemias; Immunoglobulin G; Male; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Scavenger Receptors, Class E; Technetium | 2008 |
Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Topics: Animal Feed; Animals; Annexin A5; Aorta; Apolipoproteins E; Atherosclerosis; Blood Glucose; Body Weight; Cholesterol; Dietary Fats; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organotechnetium Compounds | 2008 |
In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis.
Topics: Animals; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Positron-Emission Tomography; Rabbits; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Random Allocation | 2009 |
Monitoring plaque composition: is it worthwile?
Topics: Animals; Atherosclerosis; Diet, Atherogenic; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Positron-Emission Tomography; Rabbits; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals | 2009 |
Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2009 |
Time-to-time correlation of high-risk atherosclerotic lesions identified with [(18)F]-FDG-PET/CT.
Topics: Atherosclerosis; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Subtraction Technique; Time Factors; Tomography, X-Ray Computed | 2009 |
Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Topics: Animals; Atherosclerosis; Contrast Media; Fluorodeoxyglucose F18; Inflammation; Macrophages; Male; Positron-Emission Tomography; Rabbits; Radiographic Image Enhancement; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Vascular inflammation imaging with 18F-FDG PET/CT: when to image?
Topics: Aged; Aortic Aneurysm, Abdominal; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
Topics: Aged; Atherosclerosis; Calcium; Carotid Artery Diseases; Collagen; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Inflammation; Lipids; Magnetic Resonance Angiography; Male; Middle Aged; Necrosis; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
Vascular imaging with 18F-FDG PET/CT: optimal 18F-FDG circulation time?
Topics: Aged; Aortic Aneurysm, Abdominal; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease.
Topics: Aged; Arteries; Atherosclerosis; Calcinosis; Cardiovascular Diseases; Cerebrovascular Disorders; Cohort Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Inflammation; Male; Middle Aged; Neoplasms; Nuclear Medicine; Positron-Emission Tomography; Prognosis; Radiology; Risk; Sex Characteristics; Survival Analysis; Tomography, X-Ray Computed; Vascular Diseases | 2009 |
FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Atorvastatin; Catheterization; Cholesterol, Dietary; Diagnosis, Differential; Disease Models, Animal; Fluorodeoxyglucose F18; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Male; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Rabbits; Radiopharmaceuticals | 2010 |
Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
Topics: Aged; Angiography; Arteries; Atherosclerosis; Biomarkers; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2009 |
Imaging inflammation in atherosclerosis another step forward.
Topics: Animals; Atherosclerosis; Endothelium, Vascular; Fluorodeoxyglucose F18; Humans; Inflammation; Inflammation Mediators; Ligands; Peptides; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2009 |
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Atorvastatin; Binding, Competitive; Cells, Cultured; Contrast Media; Disease Models, Animal; Endothelium, Vascular; Feasibility Studies; Fluorodeoxyglucose F18; Graft Rejection; Half-Life; Heart Transplantation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Iopamidol; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Peptides; Positron-Emission Tomography; Predictive Value of Tests; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; RNA, Messenger; Tissue Distribution; Tomography, X-Ray Computed; Vascular Cell Adhesion Molecule-1 | 2009 |
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis.
Topics: Aged; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Constriction, Pathologic; Female; Fluorodeoxyglucose F18; Humans; Isoquinolines; Ligands; Macrophages; Male; Middle Aged; Receptors, GABA; Receptors, GABA-A | 2010 |
What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque.
Topics: Adult; Aged; Atherosclerosis; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2010 |
[PET/CT imaging of atherosclerotic blood vessel alterations].
Topics: Aged; Aged, 80 and over; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2010 |
Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Biological Transport; Biomarkers; Cardiovascular Diseases; Coronary Angiography; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2010 |
(18)F-FDG in distinction of atherosclerotic plaque: Innovation in PET/MRI technology.
Topics: Aged; Atherosclerosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Atherosclerosis; Biomarkers; Carotid Arteries; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Fatty Acid-Binding Proteins; Fluorodeoxyglucose F18; Hemodynamics; Humans; Leptin; Lipids; Male; Metabolic Syndrome; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Risk Factors; Tunica Intima; Ultrasonography; Vasculitis | 2011 |
Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Topics: Animals; Aorta; Atherosclerosis; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits | 2011 |
Quantification of [18F]-FDG uptake in atherosclerotic plaque: impact of renal function.
Topics: Adult; Aged; Atherosclerosis; Female; Fluorodeoxyglucose F18; Glomerular Filtration Rate; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Risk Factors; Tomography, X-Ray Computed | 2011 |
Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans.
Topics: Aged; Atherosclerosis; Biomarkers; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Eye Proteins; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Male; Middle Aged; Nerve Growth Factors; Positron-Emission Tomography; Serpins | 2011 |
Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography.
Topics: Aorta; Atherosclerosis; Cytokines; Endothelial Cells; Fluorodeoxyglucose F18; Foam Cells; Glucose; Humans; Hydrolysis; Hypoxia; Inflammation; Macrophages; Monocytes; Myocytes, Smooth Muscle; Positron-Emission Tomography | 2011 |
Imaging atherosclerosis with F18-fluorodeoxyglucose positron emission tomography: What are we actually seeing?
Topics: Atherosclerosis; Cardiology; Clinical Trials as Topic; Cytokines; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Hypoxia; Inflammation; Macrophages; Positron-Emission Tomography; Research Design | 2011 |
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortography; Atherosclerosis; Biomarkers; Contrast Media; Disease Models, Animal; Disease Progression; Fluorodeoxyglucose F18; Immunohistochemistry; Inflammation; Lipids; Macrophages; Magnetic Resonance Angiography; Multimodal Imaging; Neovascularization, Pathologic; Pioglitazone; Positron-Emission Tomography; PPAR gamma; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Thiazolidinediones; Time Factors; Tomography, X-Ray Computed | 2011 |
Imaging inflammatory changes in atherosclerosis multimodal imaging hitting stride.
Topics: Animals; Anti-Inflammatory Agents; Aorta; Aortic Diseases; Aortography; Atherosclerosis; Carotid Artery Diseases; Contrast Media; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Intolerance; Humans; Hypoglycemic Agents; Inflammation; Magnetic Resonance Angiography; Male; Multimodal Imaging; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sulfonylurea Compounds; Thiazolidinediones; Tomography, X-Ray Computed | 2011 |
Distribution of inflammation within carotid atherosclerotic plaques with high-risk morphological features: a comparison between positron emission tomography activity, plaque morphology, and histopathology.
Topics: Aged; Atherosclerosis; Carotid Stenosis; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Iopamidol; Male; Middle Aged; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2012 |
Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Topics: Age Factors; Aging; Animals; Aorta; Aortography; Apolipoprotein B-100; Atherosclerosis; Autoradiography; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Fluorodeoxyglucose F18; Immunohistochemistry; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, IGF Type 2; Receptors, LDL; Risk Factors; Tomography, X-Ray Computed | 2011 |
Determinants of FDG uptake in atherosclerosis.
Topics: Aging; Animals; Atherosclerosis; Diabetes Mellitus, Type 2; Diet, High-Fat; Fluorodeoxyglucose F18; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2011 |
Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.
Topics: Aged; Antineoplastic Agents; Atherosclerosis; Female; Fluorodeoxyglucose F18; Glycation End Products, Advanced; Humans; Male; Middle Aged; Positron-Emission Tomography | 2012 |
(18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers.
Topics: Animals; Atherosclerosis; Biomarkers; Fluorodeoxyglucose F18; Gene Expression Regulation; Linear Models; Mice; Multivariate Analysis; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Long-term changes of aortic 18F-FDG uptake and calcification in health-screening subjects.
Topics: Adult; Aged; Aorta; Atherosclerosis; Biological Transport; Calcinosis; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Health; Humans; Male; Mass Screening; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2013 |
18F-choline images murine atherosclerotic plaques ex vivo.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Autoradiography; Choline; Choline Kinase; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Intravascular radiation detectors for the detection of vulnerable atheroma.
Topics: Animals; Atherosclerosis; Catheterization; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Radioactive Tracers; Radiology, Interventional; Radionuclide Imaging | 2006 |
A catheter-based intravascular radiation detector of vulnerable plaques.
Topics: Animals; Atherosclerosis; Cardiac Catheterization; Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Dogs; Equipment Design; Femoral Artery; Fluorodeoxyglucose F18; Myocardial Infarction | 2006 |
Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries.
Topics: Animals; Aorta; Apolipoprotein B-48; Arteries; Atherosclerosis; Autoradiography; Calcinosis; Carotid Stenosis; Femoral Artery; Fluorodeoxyglucose F18; Humans; Inflammation; Mice; Mice, Knockout; Receptors, LDL; Tissue Distribution | 2006 |
Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Atherosclerosis; Body Weight; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Positron-Emission Tomography; Rabbits; Tomography, X-Ray Computed | 2006 |
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Topics: Aged; Atherosclerosis; Carotid Stenosis; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Macrophages; Male; Middle Aged; Positron-Emission Tomography | 2006 |
Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aorta; Aortic Diseases; Atherosclerosis; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2006 |
Fluorodeoxyglucose and calcium uptake in the vascular wall: clinically relevant or sugar-coated pill?
Topics: Atherosclerosis; Calcinosis; Calcium; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice.
Topics: Animals; Annexin A5; Apolipoproteins E; Atherosclerosis; Disease Models, Animal; Fluorodeoxyglucose F18; Mice; Mice, Knockout; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Simvastatin and plaque inflammation.
Topics: Atherosclerosis; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Positron-Emission Tomography; Radiopharmaceuticals; Simvastatin | 2007 |
Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates.
Topics: Atherosclerosis; Diabetic Foot; Female; Fluorodeoxyglucose F18; Humans; Leg; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic | 2007 |
The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Arteritis; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2007 |
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
Topics: Aged; Aortic Diseases; Atherosclerosis; Carotid Artery Diseases; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Arteries; Atherosclerosis; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Radionuclide techniques for identifying vulnerable plaque.
Topics: Atherosclerosis; Biomarkers; Carotid Stenosis; Fluorodeoxyglucose F18; History, 19th Century; Humans; Radionuclide Imaging; Radiopharmaceuticals | 2007 |
Neurological picture. Identifying aortic plaque inflammation as a potential cause of stroke.
Topics: Aged; Aorta, Thoracic; Aortitis; Atherosclerosis; Diagnosis, Differential; Dysarthria; Fluorodeoxyglucose F18; Hemiplegia; Humans; Intracranial Embolism; Magnetic Resonance Imaging; Male; Positron-Emission Tomography | 2008 |
Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.
Topics: Animals; Aortic Diseases; Atherosclerosis; C-Reactive Protein; Cholesterol, Dietary; Fluorodeoxyglucose F18; Macrophages; Male; Plasminogen Activator Inhibitor 1; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Sensitivity and Specificity; Thrombosis; Tomography, X-Ray Computed; Vasculitis | 2008 |
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.
Topics: Animals; Aortic Diseases; Area Under Curve; Atherosclerosis; Catheterization; Cholesterol, Dietary; Contrast Media; Disease Models, Animal; Fluorodeoxyglucose F18; Gadolinium DTPA; Magnetic Resonance Angiography; Male; Neovascularization, Pathologic; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Research Design | 2008 |
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.
Topics: Arteritis; Atherosclerosis; Carotid Arteries; Female; Femoral Artery; Fluorodeoxyglucose F18; Humans; Iliac Artery; Image Interpretation, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |